First Study of a Combination Between the AstraZeneca Vaccine and the First Component of ... - Latest Tweet by Prasar Bharati News Services

First study of a combination between the AstraZeneca vaccine and the first component of the Sputnik V vaccine (Sputnik Light) in Azerbaijan shows no serious adverse events or COVID infection cases following the vaccination: Russian Direct Investment Fund (RDIF)— Prasar Bharati News Services पी.बी.एन.एस. (@PBNS_India) July 30, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)